{"gene":"GALR3","run_date":"2026-04-28T18:06:52","timeline":{"discoveries":[{"year":1998,"finding":"GALR3 was cloned from rat hypothalamus cDNA and encodes a 370 amino acid GPCR with 35% and 52% identity to GALR1 and GALR2, respectively. It binds porcine 125I-galanin with high affinity (rat KD = 0.98 nM, human KD = 2.23 nM), and activation of rat and human GALR3 co-expressed with GIRK1 and GIRK4 potassium channel subunits in Xenopus oocytes produces inward K+ currents, demonstrating Gi/Go-coupled signaling.","method":"Expression cloning, radioligand binding assay, Xenopus oocyte electrophysiology with GIRK1/GIRK4 co-expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in Xenopus oocytes with functional electrophysiology, radioligand binding, and mutagenesis-level pharmacology; foundational cloning paper with 221 citations","pmids":["9722565"],"is_preprint":false},{"year":1998,"finding":"Human GALR3 signals predominantly through inhibition of adenylate cyclase (Gi-coupled pathway), in contrast to GALR2 which couples to phospholipase C and intracellular calcium elevation. The human GALR3 gene was localized to chromosome 22q12.2-13.1.","method":"Radioligand binding, aequorin luminescence assay in HEK-293 cells, Xenopus melanophore assay, signal transduction pathway characterization","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal functional assays in two cell systems; 148 citations","pmids":["9832121"],"is_preprint":false},{"year":2002,"finding":"GalR3 mRNA in the rat CNS is discrete and highly restricted, concentrated mainly in the preoptic/hypothalamic area (paraventricular, ventromedial, dorsomedial nuclei), medial septum/diagonal band, bed nucleus of stria terminalis, medial amygdaloid nucleus, periaqueductal gray, lateral parabrachial nucleus, dorsal raphe nucleus, locus coeruleus, and spinal cord laminae I-II; this distribution is consistent with roles in food intake, fluid homeostasis, cardiovascular function, and nociception.","method":"In situ hybridization (solution hybridization/RNase protection)","journal":"Journal of chemical neuroanatomy","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiment; 174 citations but single method","pmids":["12406501"],"is_preprint":false},{"year":2004,"finding":"GalR3 protein is highly expressed in the locus coeruleus and colocalizes with tyrosine hydroxylase in catecholaminergic brain areas including VTA, substantia nigra, nucleus accumbens, and locus coeruleus, suggesting a role in galanin-mediated regulation of noradrenergic transmission.","method":"Immunohistochemistry with double-labeling for tyrosine hydroxylase","journal":"The Journal of comparative neurology","confidence":"Medium","confidence_rationale":"Tier 3 — immunolocalization with functional inference; replicated across multiple brain regions","pmids":["15514977"],"is_preprint":false},{"year":2005,"finding":"Galanin (2-11), previously considered a GalR2-selective agonist, also binds rat GalR3 receptors in transfected cell lines with similar affinity as GalR2, and the antagonists M35 and M40 are not subtype-selective, indicating that prior pharmacological data attributed to GalR2 may reflect combined GalR2/GalR3 activity.","method":"Radioligand binding competition assay in transfected cell lines","journal":"Neuropeptides","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding assay in recombinant system; important pharmacological re-characterization","pmids":["15944007"],"is_preprint":false},{"year":2005,"finding":"GalR3 levels in the locus coeruleus are NOT regulated by cAMP-dependent mechanisms or galanin signaling, in contrast to GalR1 which is up-regulated in a cAMP-dependent manner; GalR3 protein and mRNA are unchanged in galanin knockout mice.","method":"Western blot, real-time PCR, pharmacological cAMP manipulation in Cath.a cells and galanin knockout mice","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockout plus pharmacological manipulation; epistatic placement within cAMP pathway","pmids":["15934937"],"is_preprint":false},{"year":2013,"finding":"GalR3 activation promotes survival of adult neural stem cells (NSCs) derived from mouse subventricular zone under glucolipotoxic conditions, correlating with decreased apoptosis (reduced cleaved caspase-3, increased Bcl-2) and decreased CHOP levels (unfolded protein response marker).","method":"Cell viability assay, apoptosis markers (Bcl-2, cleaved caspase-3), UPR markers (CHOP, GRP78/BiP, spliced XBP1, p-JNK) in primary NSC cultures with pharmacological receptor activation","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 — pharmacological activation with multiple mechanistic readouts in primary cells; single lab","pmids":["23927369"],"is_preprint":false},{"year":2013,"finding":"GalR3 has poor cell surface expression in recombinant systems; a modified GalR3 construct was generated that facilitates cell surface expression while maintaining wild-type receptor pharmacology, enabling a cAMP biosensor assay to detect GalR3-mediated Gi signaling (inhibition of cAMP).","method":"Receptor engineering, cell surface expression assay, cAMP biosensor HTS assay validated with LOPAC library","journal":"Assay and drug development technologies","confidence":"Medium","confidence_rationale":"Tier 2 — functional characterization of receptor trafficking defect and pharmacological validation of modified construct","pmids":["24116939"],"is_preprint":false},{"year":2017,"finding":"GalR3 (not GalR2) specifically mediates the proliferative effects of galanin (via the GalR2/3 agonist Gal 2-11) on postnatal hippocampal progenitor cells; co-treatment with the GalR3-specific antagonist SNAP 37889 completely abolished Gal 2-11-induced proliferation, while the GalR2-specific agonist M1145 had no proliferative effect.","method":"Pharmacological receptor subtype dissection using selective agonist (M1145 for GalR2) and antagonist (SNAP 37889 for GalR3) in postnatal rat hippocampal progenitor cell cultures","journal":"Neuropeptides","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological epistasis with subtype-selective tools; convergent positive and negative pharmacology","pmids":["28431685"],"is_preprint":false},{"year":2020,"finding":"In GnRH neurons, palmitate-induced upregulation of Galr3 mRNA involves activation of TLR4 (innate immune receptor) and is differentially regulated by PKC, JNK, ERK, and p38 kinases, but not ceramide production, placing GALR3 expression downstream of fatty acid/TLR4 signaling.","method":"Pharmacological inhibitor studies (TLR4, PKC, JNK, ERK, p38, ceramide pathway), RT-PCR in mHypoA-GnRH/GFP neuronal cell line","journal":"Molecular and cellular endocrinology","confidence":"Low","confidence_rationale":"Tier 3 — single cell line, pharmacological inhibitors only, no direct GALR3 protein function assay","pmids":["32841709"],"is_preprint":false}],"current_model":"GALR3 is a Gi/Go-coupled GPCR that binds galanin with high affinity and signals primarily through inhibition of adenylate cyclase and activation of GIRK potassium channels; it is expressed in restricted hypothalamic, limbic, and brainstem regions, shows poor cell surface trafficking in recombinant systems, mediates neuroprotective and proliferative effects on neural stem/progenitor cells via anti-apoptotic and anti-UPR pathways, and its expression is regulated by TLR4-linked fatty acid signaling but not by cAMP-dependent feedback (unlike GalR1)."},"narrative":{"teleology":[{"year":1998,"claim":"The identity and signaling mechanism of a third galanin receptor subtype were established: GALR3 was cloned, shown to bind galanin with high affinity, and demonstrated to activate GIRK potassium channels and inhibit adenylate cyclase via Gi/Go coupling, distinguishing its signaling from the PLC-coupled GALR2.","evidence":"Expression cloning from rat hypothalamus, radioligand binding, Xenopus oocyte electrophysiology with GIRK1/GIRK4, aequorin luminescence in HEK-293 cells, and melanophore assay","pmids":["9722565","9832121"],"confidence":"High","gaps":["No structural model of GALR3 or basis for Gi selectivity over other G proteins","Endogenous neuronal signaling not yet confirmed"]},{"year":2002,"claim":"The CNS expression map of GALR3 was defined, revealing a highly restricted distribution in hypothalamic, limbic, and brainstem nuclei consistent with roles in feeding, autonomic, and nociceptive circuits—constraining where GALR3 could act in vivo.","evidence":"In situ hybridization and RNase protection in rat brain","pmids":["12406501"],"confidence":"Medium","gaps":["Single detection method (mRNA only); protein-level confirmation needed","Functional consequence of expression in each nucleus not tested"]},{"year":2004,"claim":"Protein-level expression of GALR3 in catecholaminergic neurons was established by colocalization with tyrosine hydroxylase in the locus coeruleus, VTA, and substantia nigra, linking GALR3 to regulation of noradrenergic and dopaminergic transmission.","evidence":"Double-label immunohistochemistry in rat brain","pmids":["15514977"],"confidence":"Medium","gaps":["Antibody specificity not validated in GALR3-knockout tissue","No electrophysiological or biochemical evidence that GALR3 modulates catecholamine release"]},{"year":2005,"claim":"Pharmacological reassessment revealed that galanin(2-11) and the antagonists M35/M40 are not GalR2-selective but also engage GalR3, requiring reinterpretation of earlier in vivo studies, while GalR3 expression in the locus coeruleus was shown to be independent of cAMP-dependent regulation and galanin availability.","evidence":"Radioligand binding competition in transfected cells; Western blot and RT-PCR in Cath.a cells and galanin knockout mice","pmids":["15944007","15934937"],"confidence":"Medium","gaps":["Mechanism controlling GALR3 basal expression remains unknown","Lack of truly selective GALR3 agonists limits in vivo functional dissection"]},{"year":2013,"claim":"A functional role for GALR3 beyond classical neuromodulation was revealed: GALR3 activation protects adult neural stem cells from glucolipotoxicity-induced apoptosis by reducing cleaved caspase-3, increasing Bcl-2, and suppressing the unfolded protein response marker CHOP, while its poor cell-surface trafficking in recombinant systems was formally characterized.","evidence":"Apoptosis and UPR marker assays in primary SVZ-derived NSCs; receptor engineering and cAMP biosensor assay for surface expression","pmids":["23927369","24116939"],"confidence":"Medium","gaps":["Anti-apoptotic signaling pathway downstream of Gi coupling not fully delineated","Poor surface trafficking mechanism unresolved—no structural or chaperone basis identified","Neuroprotective role tested in single lab and single stress paradigm"]},{"year":2017,"claim":"GALR3, not GALR2, was identified as the receptor mediating galanin-driven proliferation of postnatal hippocampal progenitor cells, resolved through pharmacological epistasis with subtype-selective tools.","evidence":"Selective GalR3 antagonist SNAP 37889 abolished Gal(2-11)-induced proliferation; GalR2 agonist M1145 had no effect in rat hippocampal progenitor cultures","pmids":["28431685"],"confidence":"Medium","gaps":["Genetic confirmation (GALR3 knockdown/knockout in progenitors) not performed","Downstream proliferative signaling pathway from GALR3 not characterized"]},{"year":2020,"claim":"Transcriptional regulation of GALR3 was placed downstream of TLR4-mediated fatty acid sensing, with PKC, JNK, ERK, and p38 kinases controlling palmitate-induced Galr3 upregulation in hypothalamic GnRH neurons.","evidence":"Pharmacological inhibitor panel and RT-PCR in mHypoA-GnRH/GFP cell line","pmids":["32841709"],"confidence":"Low","gaps":["Single immortalized cell line with pharmacological inhibitors only; no genetic validation of TLR4 requirement","Functional consequence of GALR3 upregulation in GnRH neurons not tested","Relevance to in vivo metabolic or reproductive regulation unconfirmed"]},{"year":null,"claim":"Key unresolved questions include the structural basis of GALR3's poor surface trafficking, the downstream signaling intermediates connecting Gi coupling to anti-apoptotic and proliferative outcomes in neural progenitors, and in vivo validation of GALR3-specific functions using genetic loss-of-function models.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No GALR3-selective agonist validated in vivo","No GALR3-knockout phenotypic characterization published in the timeline","Structural basis for receptor subtype selectivity and trafficking unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,7]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,3]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[2,3,8]}],"complexes":[],"partners":["KCNJ3","KCNJ5","GAL"],"other_free_text":[]},"mechanistic_narrative":"GALR3 is a Gi/Go-coupled G protein-coupled receptor for galanin that functions in neuromodulation, neural stem/progenitor cell survival, and hippocampal progenitor proliferation. It binds galanin with high affinity (KD ~1–2 nM) and signals primarily through inhibition of adenylate cyclase and activation of GIRK potassium channels, producing inward K+ currents consistent with inhibitory neuromodulation [PMID:9722565, PMID:9832121]. GALR3 mRNA and protein are expressed in restricted hypothalamic, limbic, and brainstem nuclei—including the locus coeruleus where it colocalizes with tyrosine hydroxylase—implicating it in regulation of noradrenergic, feeding, and nociceptive circuits [PMID:12406501, PMID:15514977]. GALR3 activation promotes neural stem cell survival under glucolipotoxic stress by suppressing apoptosis and the unfolded protein response, and specifically mediates galanin-driven proliferation of postnatal hippocampal progenitors [PMID:23927369, PMID:28431685]."},"prefetch_data":{"uniprot":{"accession":"O60755","full_name":"Galanin receptor type 3","aliases":[],"length_aa":368,"mass_kda":39.6,"function":"Receptor for the hormone galanin (PubMed:25691535). Receptor for the hormone spexin-1 (PubMed:24517231)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/O60755/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GALR3","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GALR3","total_profiled":1310},"omim":[{"mim_id":"619246","title":"SPEXIN HORMONE; SPX","url":"https://www.omim.org/entry/619246"},{"mim_id":"607422","title":"GLYCINE C-ACETYLTRANSFERASE; GCAT","url":"https://www.omim.org/entry/607422"},{"mim_id":"603692","title":"GALANIN RECEPTOR 3; GALR3","url":"https://www.omim.org/entry/603692"},{"mim_id":"603691","title":"GALANIN RECEPTOR 2; GALR2","url":"https://www.omim.org/entry/603691"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Not detected","tissue_distribution":"Not detected","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GALR3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"O60755","domains":[{"cath_id":"1.20.1070.10","chopping":"17-319","consensus_level":"high","plddt":88.9648,"start":17,"end":319}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60755","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60755-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60755-F1-predicted_aligned_error_v6.png","plddt_mean":81.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GALR3","jax_strain_url":"https://www.jax.org/strain/search?query=GALR3"},"sequence":{"accession":"O60755","fasta_url":"https://rest.uniprot.org/uniprotkb/O60755.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60755/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60755"}},"corpus_meta":[{"pmid":"9722565","id":"PMC_9722565","title":"Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9722565","citation_count":221,"is_preprint":false},{"pmid":"12406501","id":"PMC_12406501","title":"Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system.","date":"2002","source":"Journal of chemical neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/12406501","citation_count":174,"is_preprint":false},{"pmid":"9832121","id":"PMC_9832121","title":"Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3.","date":"1998","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9832121","citation_count":148,"is_preprint":false},{"pmid":"15514977","id":"PMC_15514977","title":"Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain.","date":"2004","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15514977","citation_count":60,"is_preprint":false},{"pmid":"15944007","id":"PMC_15944007","title":"Galanin (2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes.","date":"2005","source":"Neuropeptides","url":"https://pubmed.ncbi.nlm.nih.gov/15944007","citation_count":54,"is_preprint":false},{"pmid":"17083333","id":"PMC_17083333","title":"Alcoholism is associated with GALR3 but not two other galanin receptor genes.","date":"2006","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/17083333","citation_count":50,"is_preprint":false},{"pmid":"23927369","id":"PMC_23927369","title":"GalR3 activation promotes adult neural stem cell survival in response to a diabetic milieu.","date":"2013","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23927369","citation_count":30,"is_preprint":false},{"pmid":"15934937","id":"PMC_15934937","title":"GalR1, but not GalR2 or GalR3, levels are regulated by galanin signaling in the locus coeruleus through a cyclic AMP-dependent mechanism.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15934937","citation_count":29,"is_preprint":false},{"pmid":"32841709","id":"PMC_32841709","title":"Palmitate differentially regulates Spexin, and its receptors Galr2 and Galr3, in GnRH neurons through mechanisms involving PKC, MAPKs, and TLR4.","date":"2020","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/32841709","citation_count":24,"is_preprint":false},{"pmid":"18595677","id":"PMC_18595677","title":"Immunohistochemical localization of galanin receptors (GAL-R1, GAL-R2, and GAL-R3) on myenteric neurons from the sheep and dog stomach.","date":"2008","source":"Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","url":"https://pubmed.ncbi.nlm.nih.gov/18595677","citation_count":13,"is_preprint":false},{"pmid":"36551197","id":"PMC_36551197","title":"Galanin Receptors (GALR1, GALR2, and GALR3) Immunoexpression in Enteric Plexuses of Colorectal Cancer Patients: Correlation with the Clinico-Pathological Parameters.","date":"2022","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/36551197","citation_count":12,"is_preprint":false},{"pmid":"24116939","id":"PMC_24116939","title":"Development of a high-throughput screening-compatible cell-based functional assay to identify small molecule probes of the galanin 3 receptor (GalR3).","date":"2013","source":"Assay and drug development technologies","url":"https://pubmed.ncbi.nlm.nih.gov/24116939","citation_count":12,"is_preprint":false},{"pmid":"35346778","id":"PMC_35346778","title":"Effects of intracerebroventricular injection of spexin and its interaction with NPY, GalR2 and GalR3 receptors on the central food intake regulation and nutritional behavior in broiler chickens.","date":"2022","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/35346778","citation_count":10,"is_preprint":false},{"pmid":"27175780","id":"PMC_27175780","title":"The Influence of Gastric Antral Ulcerations on the Expression of Galanin and GalR1, GalR2, GalR3 Receptors in the Pylorus with Regard to Gastric Intrinsic Innervation of the Pyloric Sphincter.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27175780","citation_count":10,"is_preprint":false},{"pmid":"36055012","id":"PMC_36055012","title":"Levels of spexin and its receptors GALR2 and GALR3 in the hypothalamus and ovary of letrozole-induced polycystic ovary syndrome in rats.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36055012","citation_count":6,"is_preprint":false},{"pmid":"28431685","id":"PMC_28431685","title":"GalR3 mediates galanin proliferative effects on postnatal hippocampal precursors.","date":"2017","source":"Neuropeptides","url":"https://pubmed.ncbi.nlm.nih.gov/28431685","citation_count":5,"is_preprint":false},{"pmid":"38632282","id":"PMC_38632282","title":"Glyphosate-induced changes in the expression of galanin and GALR1, GALR2 and GALR3 receptors in the porcine small intestine wall.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38632282","citation_count":3,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10761,"output_tokens":2506,"usd":0.034937},"stage2":{"model":"claude-opus-4-6","input_tokens":5815,"output_tokens":2197,"usd":0.126},"total_usd":0.160937,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"GALR3 was cloned from rat hypothalamus cDNA and encodes a 370 amino acid GPCR with 35% and 52% identity to GALR1 and GALR2, respectively. It binds porcine 125I-galanin with high affinity (rat KD = 0.98 nM, human KD = 2.23 nM), and activation of rat and human GALR3 co-expressed with GIRK1 and GIRK4 potassium channel subunits in Xenopus oocytes produces inward K+ currents, demonstrating Gi/Go-coupled signaling.\",\n      \"method\": \"Expression cloning, radioligand binding assay, Xenopus oocyte electrophysiology with GIRK1/GIRK4 co-expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in Xenopus oocytes with functional electrophysiology, radioligand binding, and mutagenesis-level pharmacology; foundational cloning paper with 221 citations\",\n      \"pmids\": [\"9722565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Human GALR3 signals predominantly through inhibition of adenylate cyclase (Gi-coupled pathway), in contrast to GALR2 which couples to phospholipase C and intracellular calcium elevation. The human GALR3 gene was localized to chromosome 22q12.2-13.1.\",\n      \"method\": \"Radioligand binding, aequorin luminescence assay in HEK-293 cells, Xenopus melanophore assay, signal transduction pathway characterization\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal functional assays in two cell systems; 148 citations\",\n      \"pmids\": [\"9832121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GalR3 mRNA in the rat CNS is discrete and highly restricted, concentrated mainly in the preoptic/hypothalamic area (paraventricular, ventromedial, dorsomedial nuclei), medial septum/diagonal band, bed nucleus of stria terminalis, medial amygdaloid nucleus, periaqueductal gray, lateral parabrachial nucleus, dorsal raphe nucleus, locus coeruleus, and spinal cord laminae I-II; this distribution is consistent with roles in food intake, fluid homeostasis, cardiovascular function, and nociception.\",\n      \"method\": \"In situ hybridization (solution hybridization/RNase protection)\",\n      \"journal\": \"Journal of chemical neuroanatomy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment; 174 citations but single method\",\n      \"pmids\": [\"12406501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GalR3 protein is highly expressed in the locus coeruleus and colocalizes with tyrosine hydroxylase in catecholaminergic brain areas including VTA, substantia nigra, nucleus accumbens, and locus coeruleus, suggesting a role in galanin-mediated regulation of noradrenergic transmission.\",\n      \"method\": \"Immunohistochemistry with double-labeling for tyrosine hydroxylase\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — immunolocalization with functional inference; replicated across multiple brain regions\",\n      \"pmids\": [\"15514977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Galanin (2-11), previously considered a GalR2-selective agonist, also binds rat GalR3 receptors in transfected cell lines with similar affinity as GalR2, and the antagonists M35 and M40 are not subtype-selective, indicating that prior pharmacological data attributed to GalR2 may reflect combined GalR2/GalR3 activity.\",\n      \"method\": \"Radioligand binding competition assay in transfected cell lines\",\n      \"journal\": \"Neuropeptides\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding assay in recombinant system; important pharmacological re-characterization\",\n      \"pmids\": [\"15944007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GalR3 levels in the locus coeruleus are NOT regulated by cAMP-dependent mechanisms or galanin signaling, in contrast to GalR1 which is up-regulated in a cAMP-dependent manner; GalR3 protein and mRNA are unchanged in galanin knockout mice.\",\n      \"method\": \"Western blot, real-time PCR, pharmacological cAMP manipulation in Cath.a cells and galanin knockout mice\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout plus pharmacological manipulation; epistatic placement within cAMP pathway\",\n      \"pmids\": [\"15934937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GalR3 activation promotes survival of adult neural stem cells (NSCs) derived from mouse subventricular zone under glucolipotoxic conditions, correlating with decreased apoptosis (reduced cleaved caspase-3, increased Bcl-2) and decreased CHOP levels (unfolded protein response marker).\",\n      \"method\": \"Cell viability assay, apoptosis markers (Bcl-2, cleaved caspase-3), UPR markers (CHOP, GRP78/BiP, spliced XBP1, p-JNK) in primary NSC cultures with pharmacological receptor activation\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — pharmacological activation with multiple mechanistic readouts in primary cells; single lab\",\n      \"pmids\": [\"23927369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GalR3 has poor cell surface expression in recombinant systems; a modified GalR3 construct was generated that facilitates cell surface expression while maintaining wild-type receptor pharmacology, enabling a cAMP biosensor assay to detect GalR3-mediated Gi signaling (inhibition of cAMP).\",\n      \"method\": \"Receptor engineering, cell surface expression assay, cAMP biosensor HTS assay validated with LOPAC library\",\n      \"journal\": \"Assay and drug development technologies\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional characterization of receptor trafficking defect and pharmacological validation of modified construct\",\n      \"pmids\": [\"24116939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GalR3 (not GalR2) specifically mediates the proliferative effects of galanin (via the GalR2/3 agonist Gal 2-11) on postnatal hippocampal progenitor cells; co-treatment with the GalR3-specific antagonist SNAP 37889 completely abolished Gal 2-11-induced proliferation, while the GalR2-specific agonist M1145 had no proliferative effect.\",\n      \"method\": \"Pharmacological receptor subtype dissection using selective agonist (M1145 for GalR2) and antagonist (SNAP 37889 for GalR3) in postnatal rat hippocampal progenitor cell cultures\",\n      \"journal\": \"Neuropeptides\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological epistasis with subtype-selective tools; convergent positive and negative pharmacology\",\n      \"pmids\": [\"28431685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In GnRH neurons, palmitate-induced upregulation of Galr3 mRNA involves activation of TLR4 (innate immune receptor) and is differentially regulated by PKC, JNK, ERK, and p38 kinases, but not ceramide production, placing GALR3 expression downstream of fatty acid/TLR4 signaling.\",\n      \"method\": \"Pharmacological inhibitor studies (TLR4, PKC, JNK, ERK, p38, ceramide pathway), RT-PCR in mHypoA-GnRH/GFP neuronal cell line\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single cell line, pharmacological inhibitors only, no direct GALR3 protein function assay\",\n      \"pmids\": [\"32841709\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GALR3 is a Gi/Go-coupled GPCR that binds galanin with high affinity and signals primarily through inhibition of adenylate cyclase and activation of GIRK potassium channels; it is expressed in restricted hypothalamic, limbic, and brainstem regions, shows poor cell surface trafficking in recombinant systems, mediates neuroprotective and proliferative effects on neural stem/progenitor cells via anti-apoptotic and anti-UPR pathways, and its expression is regulated by TLR4-linked fatty acid signaling but not by cAMP-dependent feedback (unlike GalR1).\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GALR3 is a Gi/Go-coupled G protein-coupled receptor for galanin that functions in neuromodulation, neural stem/progenitor cell survival, and hippocampal progenitor proliferation. It binds galanin with high affinity (KD ~1–2 nM) and signals primarily through inhibition of adenylate cyclase and activation of GIRK potassium channels, producing inward K+ currents consistent with inhibitory neuromodulation [PMID:9722565, PMID:9832121]. GALR3 mRNA and protein are expressed in restricted hypothalamic, limbic, and brainstem nuclei—including the locus coeruleus where it colocalizes with tyrosine hydroxylase—implicating it in regulation of noradrenergic, feeding, and nociceptive circuits [PMID:12406501, PMID:15514977]. GALR3 activation promotes neural stem cell survival under glucolipotoxic stress by suppressing apoptosis and the unfolded protein response, and specifically mediates galanin-driven proliferation of postnatal hippocampal progenitors [PMID:23927369, PMID:28431685].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"The identity and signaling mechanism of a third galanin receptor subtype were established: GALR3 was cloned, shown to bind galanin with high affinity, and demonstrated to activate GIRK potassium channels and inhibit adenylate cyclase via Gi/Go coupling, distinguishing its signaling from the PLC-coupled GALR2.\",\n      \"evidence\": \"Expression cloning from rat hypothalamus, radioligand binding, Xenopus oocyte electrophysiology with GIRK1/GIRK4, aequorin luminescence in HEK-293 cells, and melanophore assay\",\n      \"pmids\": [\"9722565\", \"9832121\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural model of GALR3 or basis for Gi selectivity over other G proteins\",\n        \"Endogenous neuronal signaling not yet confirmed\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"The CNS expression map of GALR3 was defined, revealing a highly restricted distribution in hypothalamic, limbic, and brainstem nuclei consistent with roles in feeding, autonomic, and nociceptive circuits—constraining where GALR3 could act in vivo.\",\n      \"evidence\": \"In situ hybridization and RNase protection in rat brain\",\n      \"pmids\": [\"12406501\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single detection method (mRNA only); protein-level confirmation needed\",\n        \"Functional consequence of expression in each nucleus not tested\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Protein-level expression of GALR3 in catecholaminergic neurons was established by colocalization with tyrosine hydroxylase in the locus coeruleus, VTA, and substantia nigra, linking GALR3 to regulation of noradrenergic and dopaminergic transmission.\",\n      \"evidence\": \"Double-label immunohistochemistry in rat brain\",\n      \"pmids\": [\"15514977\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Antibody specificity not validated in GALR3-knockout tissue\",\n        \"No electrophysiological or biochemical evidence that GALR3 modulates catecholamine release\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Pharmacological reassessment revealed that galanin(2-11) and the antagonists M35/M40 are not GalR2-selective but also engage GalR3, requiring reinterpretation of earlier in vivo studies, while GalR3 expression in the locus coeruleus was shown to be independent of cAMP-dependent regulation and galanin availability.\",\n      \"evidence\": \"Radioligand binding competition in transfected cells; Western blot and RT-PCR in Cath.a cells and galanin knockout mice\",\n      \"pmids\": [\"15944007\", \"15934937\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism controlling GALR3 basal expression remains unknown\",\n        \"Lack of truly selective GALR3 agonists limits in vivo functional dissection\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"A functional role for GALR3 beyond classical neuromodulation was revealed: GALR3 activation protects adult neural stem cells from glucolipotoxicity-induced apoptosis by reducing cleaved caspase-3, increasing Bcl-2, and suppressing the unfolded protein response marker CHOP, while its poor cell-surface trafficking in recombinant systems was formally characterized.\",\n      \"evidence\": \"Apoptosis and UPR marker assays in primary SVZ-derived NSCs; receptor engineering and cAMP biosensor assay for surface expression\",\n      \"pmids\": [\"23927369\", \"24116939\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Anti-apoptotic signaling pathway downstream of Gi coupling not fully delineated\",\n        \"Poor surface trafficking mechanism unresolved—no structural or chaperone basis identified\",\n        \"Neuroprotective role tested in single lab and single stress paradigm\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"GALR3, not GALR2, was identified as the receptor mediating galanin-driven proliferation of postnatal hippocampal progenitor cells, resolved through pharmacological epistasis with subtype-selective tools.\",\n      \"evidence\": \"Selective GalR3 antagonist SNAP 37889 abolished Gal(2-11)-induced proliferation; GalR2 agonist M1145 had no effect in rat hippocampal progenitor cultures\",\n      \"pmids\": [\"28431685\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Genetic confirmation (GALR3 knockdown/knockout in progenitors) not performed\",\n        \"Downstream proliferative signaling pathway from GALR3 not characterized\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Transcriptional regulation of GALR3 was placed downstream of TLR4-mediated fatty acid sensing, with PKC, JNK, ERK, and p38 kinases controlling palmitate-induced Galr3 upregulation in hypothalamic GnRH neurons.\",\n      \"evidence\": \"Pharmacological inhibitor panel and RT-PCR in mHypoA-GnRH/GFP cell line\",\n      \"pmids\": [\"32841709\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Single immortalized cell line with pharmacological inhibitors only; no genetic validation of TLR4 requirement\",\n        \"Functional consequence of GALR3 upregulation in GnRH neurons not tested\",\n        \"Relevance to in vivo metabolic or reproductive regulation unconfirmed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of GALR3's poor surface trafficking, the downstream signaling intermediates connecting Gi coupling to anti-apoptotic and proliferative outcomes in neural progenitors, and in vivo validation of GALR3-specific functions using genetic loss-of-function models.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No GALR3-selective agonist validated in vivo\",\n        \"No GALR3-knockout phenotypic characterization published in the timeline\",\n        \"Structural basis for receptor subtype selectivity and trafficking unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 7]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2, 3, 8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"KCNJ3\",\n      \"KCNJ5\",\n      \"GAL\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}